WINTER IS COMING

Weight Management

Synempic Beta - additional product image

1 / 8

Peptides Line

Synempic Beta

Name: Synempic Beta
Brand: Peptalon
SKU: PE-0197-01-5
Availability: InStock
Rating: 4.8 (127 reviews)

Synempic Beta 5 delivers tirzepatide, a dual GLP-1/GIP agonist for powerful appetite suppression, fat loss, and metabolic reset.

From $108.00

format:

Key Ingredients

Tirzepatide

Boosts Daily Energy

Promotes Weightloss

Boosts Insulin Efficiancy

Controls Appetite

Dual Hormone Action GLP1 and GIP

Improves Metabolism

Limits Fat Storage

Not sure about the right dosage?

Use our Peptide Dosage Calculator for optimal application

Main Information

Synempic Beta is a powerful next-generation injectable designed to help you take control of your metabolism and reshape your body from the inside out. Featuring Tirzepatide, a dual-action peptide that targets both GLP-1 and GIP receptors, this formula supports rapid fat loss, reduced appetite, and improved blood sugar control—without harsh stimulants or crash diets.Whether you’re aiming for a leaner physique, better energy regulation, or help overcoming cravings and plateaus, Synempic Beta works with your body’s natural systems to deliver sustainable, science-backed results.

Ideal for advanced weight management, body recomposition, or insulin resistance support.

Scientific Background

Synempic Beta features Tirzepatide, a first-in-class dual agonist of GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. Developed by Eli Lilly, Tirzepatide emerged from incretin research aimed at combining two complementary hormonal pathways to optimize glycemic control, satiety, and body composition. The goal was to go beyond GLP-1 monotherapy and create a more robust approach to metabolic dysfunction.Tirzepatide mimics the actions of both incretins, enhancing insulin release, reducing glucagon, slowing gastric emptying, and directly acting on the hypothalamus to reduce appetite. This dual mechanism delivers superior improvements in blood sugar regulation, visceral fat reduction, and overall weight loss compared to GLP-1 agonists alone.

In phase III clinical trials, patients lost an average of 15–22% of body weight, with marked improvements in insulin sensitivity, lipid profiles, and inflammatory markers—making it a breakthrough agent for obesity, type 2 diabetes, and body recomposition strategies [1][2].

Synempic Beta is ideal for individuals targeting aggressive fat loss, hormonal reset, or advanced metabolic optimization.

References

Jastreboff AM et al. Tirzepatide once weekly for weight loss in adults with obesity. N Engl J Med. 2022;387(3):205–216. doi: 10.1056/NEJMoa2206038
Frias JP et al. Tirzepatide versus Semaglutide for type 2 diabetes. N Engl J Med. 2021;385(6):503–515. doi: 10.1056/NEJMoa2107519

Usage Instructions

To ensure safe and effective use of Peptide Products, like Synempic Beta, it’s important to follow correct preparation, handling, and injection techniques. Below is a summary of the most essential steps. For detailed guidance, please refer to the official Product Leaflet included with your vial. You can also view the the Leaflet online at the right bottom of the product page.

Inspect the solution before each use by gently tipping or swirling the vial or preloaded syringe once or twice.
Do not use if the solution appears cloudy, discolored, or contains particles.
Peptide products are typically supplied as a lyophilized (freeze-dried) powder.
Reconstitute using bacteriostatic water.
Inject slowly along the vial wall and swirl gently (do not shake) until fully dissolved and clear.
This peptide is intended for subcutaneous injection using insulin syringes (up to 16 mm needle length).
Always use a new, sterile syringe and needle for every injection.
Maintain aseptic technique and never reuse syringes.
Rotate the injection sites (e.g., abdomen, thighs, or upper arm) to avoid local irritation or tissue damage.
Before injecting, check that the syringe is correctly loaded: a small drop of solution should appear at the needle tip. If not, discard the syringe and prepare a new one.
Refer to sections E–G on pages 10–11 of the Product Leaflet for visual instruction, if available.
Store the lyophilized powder refrigerated at 2–8 °C.
After reconstitution, use within 7–14 days, keeping the solution refrigerated.
Do not freeze. Protect from light.

Dosage Information

Standard Fat Loss Protocol

Start with 2.5 mg, injected once weekly, subcutaneously (abdomen, thigh, or upper arm)
Increase to 5 mg/week after 2–4 weeks if well tolerated
Maximize at 10–15 mg/week for advanced users under supervision

Metabolic Reset / Insulin Resistance Support

2.5–5 mg weekly, continued for 8–12 weeks, with dietary support
Effective when paired with low-glycemic nutrition and moderate-intensity training

Aggressive Recomposition Protocols

Titrate to 10–15 mg/week, typically in cutting cycles or post-rebound phases
Best combined with calorie restriction and recovery-focused support (e.g., amino acids, adaptogens)

Injections should be administered on the same day each week for consistency. Avoid doubling doses if a week is missed—resume as scheduled.

Important Warnings

Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 (Multiple Endocrine Neoplasia type 2)
Use caution in individuals with pancreatitis, gallbladder disorders, or severe gastrointestinal disease
Common side effects include nausea, bloating, appetite suppression, and fatigue—typically transient during titration
May delay gastric emptying—use caution with time-sensitive oral medications
Not recommended during pregnancy or breastfeeding
Hypoglycemia may occur if combined with insulin or sulfonylureas—monitor closely in diabetic patients
Must be used under medical supervision in individuals with diabetes, chronic kidney disease, or liver impairment
Always refrigerate between 2–8 °C. Discard if exposed to heat or contamination. Keep out of reach of children.

Frequently Asked Questions

What Others Have Selected

$42.00

$42.00

$48.00

$72.00

$54.00

$48.00

$48.00

$54.00

$48.00

$48.00

$54.00

Inspect the solution before each use by gently tipping or swirling the vial or preloaded syringe once or twice.
Do not use if the solution appears cloudy, discolored, or contains particles.
Peptide products are typically supplied as a lyophilized (freeze-dried) powder.
Reconstitute using bacteriostatic water.
Inject slowly along the vial wall and swirl gently (do not shake) until fully dissolved and clear.
This peptide is intended for subcutaneous injection using insulin syringes (up to 16 mm needle length).
Always use a new, sterile syringe and needle for every injection.
Maintain aseptic technique and never reuse syringes.
Rotate the injection sites (e.g., abdomen, thighs, or upper arm) to avoid local irritation or tissue damage.
Before injecting, check that the syringe is correctly loaded: a small drop of solution should appear at the needle tip. If not, discard the syringe and prepare a new one.
Refer to sections E–G on pages 10–11 of the Product Leaflet for visual instruction, if available.
Store the lyophilized powder refrigerated at 2–8 °C.
After reconstitution, use within 7–14 days, keeping the solution refrigerated.
Do not freeze. Protect from light.

Dosage Information

Standard Fat Loss Protocol

Start with 2.5 mg, injected once weekly, subcutaneously (abdomen, thigh, or upper arm)
Increase to 5 mg/week after 2–4 weeks if well tolerated
Maximize at 10–15 mg/week for advanced users under supervision

Metabolic Reset / Insulin Resistance Support

2.5–5 mg weekly, continued for 8–12 weeks, with dietary support
Effective when paired with low-glycemic nutrition and moderate-intensity training

Aggressive Recomposition Protocols

Titrate to 10–15 mg/week, typically in cutting cycles or post-rebound phases
Best combined with calorie restriction and recovery-focused support (e.g., amino acids, adaptogens)

Injections should be administered on the same day each week for consistency. Avoid doubling doses if a week is missed—resume as scheduled.

Important Warnings

Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 (Multiple Endocrine Neoplasia type 2)
Use caution in individuals with pancreatitis, gallbladder disorders, or severe gastrointestinal disease
Common side effects include nausea, bloating, appetite suppression, and fatigue—typically transient during titration
May delay gastric emptying—use caution with time-sensitive oral medications
Not recommended during pregnancy or breastfeeding
Hypoglycemia may occur if combined with insulin or sulfonylureas—monitor closely in diabetic patients
Must be used under medical supervision in individuals with diabetes, chronic kidney disease, or liver impairment
Always refrigerate between 2–8 °C. Discard if exposed to heat or contamination. Keep out of reach of children.

Featured Categories

Browse All Categories

Featured Product

Featured Collections

Browse All Collections

Discover Lines

Featured Knowledge

Browse All Knowledge

Expert Knowledge

Synempic Beta